Home › NDC Lookup › RxCUI directory › RxCUI 1548724

Prednisolone acetate 10 MG/ML Ophthalmic Suspension [Pred Forte] — RxCUI 1548724

RxNorm drug concept · Semantic branded drug
RxCUI 1548724 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1548724
Official namePrednisolone acetate 10 MG/ML Ophthalmic Suspension [Pred Forte]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPred Forte 1 % Ophthalmic Suspension; Pred Forte 10 MG/ML Ophthalmic Suspension
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)229 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Prednisolone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It calms inflammation and an overactive immune system. Depending on the product, that can mean allergic conditions, skin diseases, hormone problems, ulcerative colitis or Crohn's d...
  • Follow your prescriber's directions. The dissolving tablets should be taken with food, and you should not split them. For eye suspensions, shake the bottle well first. Don't stop e...
  • Some people notice fluid retention, higher blood sugar or blood pressure, mood changes, trouble sleeping, nausea, and more appetite with weight gain. Call your doctor for signs of...
  • Often yes, but check with me first. Warfarin, diabetes medicines, aspirin or NSAIDs, water pills, digoxin, cyclosporine, and certain seizure and antibiotic medicines can interact....
📖 Read our full Prednisolone guide →

🕸️ Concept Web — How Prednisolone acetate 10 MG/ML Ophthalmic Suspens... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Prednisolone acetate 10 MG/ML Ophthalmic Suspension [Pred Forte] RxCUI 1548724

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Prednisolone 8638
    • Prednisolone acetate 34372
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pred Forte 202844
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Prednisolone Ophthalmic Suspension 373571
    • Prednisolone acetate Ophthalmic Suspension 2645921
    • Prednisolone Ophthalmic Product 1165757
    • Prednisolone acetate Ophthalmic Product 2661078
    • Prednisolone Ophthalmic Suspension [Pred Forte] 365822
    • Prednisolone acetate Ophthalmic Suspension [Pred Forte] 2656572
    • Pred Forte Ophthalmic Product 1185239
    • Ophthalmic Suspension 316964
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Prednisolone acetate 10 MG/ML Ophthalmic Suspension SCD · 1376336
  • Prednisolone acetate 10 MG/ML SCDC · 1376335
  • Prednisolone Ophthalmic Suspension SCDF · 373571
  • Prednisolone acetate Ophthalmic Suspension SCDFP · 2645921
  • Prednisolone Ophthalmic Product SCDG · 1165757
  • Prednisolone acetate Ophthalmic Product SCDGP · 2661078

Brand-Name Concepts

  • Prednisolone acetate 10 MG/ML [Pred Forte] SBDC · 1548723
  • Prednisolone Ophthalmic Suspension [Pred Forte] SBDF · 365822
  • Prednisolone acetate Ophthalmic Suspension [Pred Forte] SBDFP · 2656572
  • Pred Forte Ophthalmic Product SBDG · 1185239
  • Pred Forte BN · 202844

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1548724 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
11980-0180-05 1 BOTTLE, DROPPER in 1 CARTON (11980-180-05) / 5 mL in 1 BO... PRED FORTE Allergan, Inc. 1973-06-01
11980-0180-10 1 BOTTLE, DROPPER in 1 CARTON (11980-180-10) / 10 mL in 1 B... PRED FORTE Allergan, Inc. 1973-06-01
Observed labelers: Allergan, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$30.7719
Range $30.7132–$30.8306 · middle 50% $30.7426–$30.8013 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.